niacinamide has been researched along with Pulmonary Arterial Remodeling in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leong, ZP | 1 |
| Hikasa, Y | 1 |
| Shaw, DE | 1 |
| Baig, F | 1 |
| Bruce, I | 1 |
| Chamoin, S | 1 |
| Collingwood, SP | 1 |
| Cross, S | 1 |
| Dayal, S | 1 |
| Drückes, P | 1 |
| Furet, P | 1 |
| Furminger, V | 1 |
| Haggart, D | 1 |
| Hussey, M | 1 |
| Konstantinova, I | 1 |
| Loren, JC | 1 |
| Molteni, V | 1 |
| Roberts, S | 1 |
| Reilly, J | 1 |
| Saunders, AM | 1 |
| Stringer, R | 1 |
| Sviridenko, L | 1 |
| Thomas, M | 1 |
| Thomson, CG | 1 |
| Tomlins, C | 1 |
| Wen, B | 1 |
| Yeh, V | 1 |
| Pearce, AC | 1 |
2 other studies available for niacinamide and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Autophagy; Disease Models, Animal; Dose-Respons | 2018 |
Optimization of Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for Duration of Action, as an Inhaled Therapy for Lung Remodeling in Pulmonary Arterial Hypertension.
Topics: Administration, Inhalation; Airway Remodeling; Animals; Cell Line; Cell Proliferation; Hypertension, | 2016 |